The development of resistance to chemotherapeutic agents is a common phenomenon in tumor cells leading to recurrence of the tumor and several lines of evidence have reported that NF-κB and PI-3K signal transduction pathways are involved in the development of resistance of tumors against a numerous of anticancer chemotherapeutic agents [49], [50], [51]. The gene discussed is NFKB1; the disease is neoplasm.